Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
About Us
News and Events
My HPRA:
Login
Register
About Us
Our Mission, Vision and Values
What We Regulate and How We Regulate
Our Strategic Plan 2021 – 2025
Contact Us
Our Structure
Patient Forum
Publications & Forms
Standards of Service
Privacy and Data Protection
Information and transparency
Consultations
Quality Management
Recruitment
Report an Issue
Legislation
Extranets
News and Events
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Safety Features – Extension of the ‘Use & Learn’ Phase in Ireland until September 9th 2019
News Category:
Regulatory news
Date:
08/05/2019
As outlined in our
previous update in February
, the Falsified Medicines Directive safety feature requirements came into effect on 9
th
February. During this time, the system in Ireland has been in ‘use and learn’ phase to ensure the continuity of safe supply of medicines to patients while all parties gained a better understanding of the new system.
The national Safety Features Oversight Group comprising the Irish Medicines Verification Organisation (IMVO), the Department of Health, the Health Products Regulatory Authority (HPRA), the Pharmaceutical Society of Ireland (PSI), the Health Service Executive (HSE) and the Private Hospitals Association (PHA) has been closely monitoring progress since go live on 9
th
February.
Taking all factors into account, the group has decided that the use and learn period will be further extended until
9th September 2019
to allow additional time for the system to stabilise. The situation will be reviewed again at that stage. For more details, and for important updates for MAHs, manufacturers and wholesalers, see below
Extension of FMD Use and Learn Period, Ireland, May 2019
« Back
Date Printed: 26/04/2024